Therapeutic efficacy and safety of pidotimod in the treatment of urinary tract infections in children

Arzneimittel-Forschung/Drug Research

Volumn 44, Issue 12 A, 1994, Pages 1490-1494

  Clemente, E ^a   Solli, R ^a   Mei, V A ^a   Cera, R ^a   Caramia, V ^a   Ruffini, E ^a   Venturoli, V ^a   Corsini, A ^a   Carnelli, V ^a  

^a Ospedale Consorziale   (Italy)

Author keywords

biological response modifiers; CAS 121808 62 6; PGT 1A; pidotimod, clinical studies; urinary tract infections in children

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL RESPONSE MODIFIER; PIDOTIMOD; PLACEBO;

ARTICLE; CHEMOTAXIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; FEMALE; HUMAN; IMMUNE RESPONSE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PHAGOCYTOSIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; SYMPTOMATOLOGY; URINARY TRACT INFECTION; VOMITING;

ANTI-INFECTIVE AGENTS, URINARY; BIOLOGICAL RESPONSE MODIFIERS; CHEMOTAXIS, LEUKOCYTE; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PHAGOCYTOSIS; PYRROLIDONECARBOXYLIC ACID; RECURRENCE; THIAZOLES; THIAZOLIDINES; URINARY TRACT INFECTIONS;

EID: 0028675265     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)